Fidaxomicin versus conventional antimicrobial therapy in 59 recipients of solid organ and hematopoietic stem cell transplantation with Clostridium difficile-associated diarrhea
about
Fidaxomicin: A novel agent for the treatment of Clostridium difficile infectionClostridium difficile Infection in Special High-Risk PopulationsAntibacterial Resistance in Patients with Hematopoietic Stem Cell Transplantation.Exploiting CRISPR-Cas to manipulate Enterococcus faecalis populations.Fidaxomicin therapy in critically ill patients with Clostridium difficile infection.Fidaxomicin--the new drug for Clostridium difficile infectionOutcomes of Clostridium difficile infection in recipients of solid abdominal organ transplantsClostridium difficile and inflammatory bowel disease: role in pathogenesis and implications in treatment.The prevention and management of infections due to multidrug resistant organisms in haematology patientsClostridium difficile: deleterious impact on hematopoietic stem cell transplantation.Challenges and opportunities in the management of Clostridium difficile infection.Symptom management in inflammatory bowel disease.The epidemiology of Clostridium difficile infection in a national kidney transplant center.Management of Clostridium difficile Infection.The epidemiology of Clostridium difficile infection in patients with cancer.A multi-center study of fidaxomicin use for Clostridium difficile infectionRethinking Strategies to Select Antibiotic Therapy in Clostridium difficile infection.The efficacy of fidaxomicin in the treatment of Clostridium difficile infection in a real-world clinical setting: a Spanish multi-centre retrospective cohort.Treatment of Clostridium difficile infection in a French university hospital.Clostridium difficile Infection (CDI) in Solid Organ and Hematopoietic Stem Cell Transplant Recipients.A different kind of “allogeneic transplant”: successful fecal microbiota transplant for recurrent and refractoryClostridium difficileinfection in a patient with relapsed aggressive B-cell lymphoma
P2860
Q26770175-83CBB7B7-00B8-4B96-B009-32C2290A1AF4Q28069414-D8A6291D-0923-4F83-8644-09343688BC39Q30238945-2A64295A-98DF-4805-A90F-DC78D18359DFQ33853796-265E2F5D-95DF-4F03-9F13-B630788F7157Q35076869-DEBF1ECF-41A7-416C-817E-E7CC48322C0FQ35877773-0B094147-015A-4005-856C-1BECE7F3104CQ37006100-10E9646D-6364-4D04-9BC5-E5A176C38573Q37334099-39A82F55-1919-41A9-B634-05C5AFF7277EQ38171538-4DD17DF6-3C76-43EC-8C54-C00E05DBDD3EQ38175865-EE725632-D809-46D8-9F30-1D4F6C79D735Q38228162-93401DA4-1065-46B1-A15F-1944D4FF786CQ38438128-49642CAE-998E-4E42-83FB-FB2F904A568CQ38744998-C568879F-7339-44B7-9D7A-9AC787466D40Q38787320-D9836415-582F-497E-ADD9-CB99FAD940F6Q38823326-F6C045F6-8FC1-4230-8B6F-843E7B5F6CD7Q38930594-F1273D8E-CD80-4E8F-AD9E-2702774720FDQ39175350-024AF08E-C405-4178-898E-8787196FDAA8Q40513250-F021546D-9C74-46B4-AAD5-EA162AA91676Q41068418-705FC02B-7AB9-42AF-AADE-807BB872CD74Q42212406-DF419372-0100-439E-81E8-79B360363888Q57746070-85F74DC4-A27A-460F-A0B9-F634252C19C6
P2860
Fidaxomicin versus conventional antimicrobial therapy in 59 recipients of solid organ and hematopoietic stem cell transplantation with Clostridium difficile-associated diarrhea
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 08 July 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Fidaxomicin versus conventiona ...... difficile-associated diarrhea
@en
Fidaxomicin versus conventiona ...... difficile-associated diarrhea.
@nl
type
label
Fidaxomicin versus conventiona ...... difficile-associated diarrhea
@en
Fidaxomicin versus conventiona ...... difficile-associated diarrhea.
@nl
prefLabel
Fidaxomicin versus conventiona ...... difficile-associated diarrhea
@en
Fidaxomicin versus conventiona ...... difficile-associated diarrhea.
@nl
P2093
P2860
P356
P1476
Fidaxomicin versus conventiona ...... difficile-associated diarrhea
@en
P2093
Amar Safdar
Dana S Clutter
Lewis Teperman
Man Yee Merl
Robert Press
Yanina Dubrovskaya
P2860
P304
P356
10.1128/AAC.01120-13
P407
P577
2013-07-08T00:00:00Z